Our aim was to evaluate the presence and distribution of SP-D in all molecular subtypes of breast cancer to dissect its biological role in neoplastic progression and to consider a potential predictive and/or prognostic marker of mammary carcinoma. Here, SFTPD is linked to breast carcinoma.